Elaboration: drug-induced agranulocytosis--monitoring antithyroid treatment.
D000380:Agranulocytosis / Q000139:chemically induced*; D013956:Antithyroid Agents / Q000009:adverse effects*; D001772:Blood Cell Count; D016903:Drug Monitoring; D006801:Humans; D008713:Methimazole / Q000009:adverse effects
D013956:Antithyroid Agents; D008713:Methimazole